My Research Interest in RESIST |
Our research focus at RESIST is to understand how the immune system can control or eliminate hepatitis viruses and to use this knowledge to develop new treatment strategies, particularly for chronic hepatitis B (HBV). Current treatment methods, such as nucleoside or nucleotide analogues (NA), are the most commonly used drugs in chronic HBV. However, these therapies only suppress the virus and rarely lead to a cure or functional cure, defined as loss of HBV surface antigen (HBsAg). Therefore, most patients require lifelong treatment, which underscores the urgent need for new approaches to achieve HBsAg loss.
To address this issue, we have initiated prospective clinical studies to evaluate a structured discontinuation or interruption of NA treatment in chronic HBV patients. The results of the first study were pivotal, demonstrating that discontinuation of NA therapy followed by a rebound in HBV DNA can trigger immune responses that drive HBsAg loss in 10–30% of cases. However, important questions remain, including identifying the key immune components required for functional cure after NA interruption and determining which patients would be likely to benefit from NA treatment discontinuation.
In addition, our research is also focused on identifying new therapeutic targets to enhance functional HBV cure, such as epigenetic mechanisms. This comprehensive approach enables RESIST to drive significant advances in the treatment of HBV and immune-mediated liver diseases.
Prof. Cornberg about his scientific work
Prof. Dr. Markus Cornberg – Curriculum Vitae
Current Positions
Undergraduate and Postgraduate Training
Academic and Research Posts
Other Scientific Roles
10 Selected Publications
Aliabadi, E., M. Urbanek-Quaing, B. Maasoumy, B. Bremer, M. Grasshoff, Y. Li, C. E. Niehaus, H. Wedemeyer, A. R. M. Kraft*, and M. Cornberg*. 2022. Impact of HBsAg and HBcrAg levels on phenotype and function of HBV-specific T cells in patients with chronic hepatitis B virus infection. Gut 71: 2300–2312. PMID: 34702717 *contributed equally.
Oltmanns, C., Z. Liu, J. Mischke, J. Tauwaldt, Y. A. Mekonnen, M. Urbanek-Quaing, J. Debarry, B. Maasoumy, H. Wedemeyer, A. R. M. Kraft, C.-J. Xu*, and M. Cornberg*. 2023. Reverse inflammaging: Long-term effects of HCV cure on biological age. J Hepatol 78: 90–98. PMID: 36152762 *contributed equally equally
Niehaus, C. E., B. Strunz, M. Cornillet, C. S. Falk, A. Schnieders, B. Maasoumy, S. Hardtke, M. P. Manns, A. R. M. Kraft*, N. K. Björkström*, and M. Cornberg*. 2020. MAIT Cells Are Enriched and Highly Functional in Ascites of Patients With Decompensated Liver Cirrhosis. Hepatology 72: 1378–1393. PMID: 32012321 *contributed equally.
Soon, C. F., P. Behrendt, D. Todt, M. P. Manns, H. Wedemeyer, M. Sällberg Chen*, and M. Cornberg*. 2019. Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E. J Hepatol 71: 673–684. PMID: 31203151 *contributed equally
Aregay, A., S. Owusu Sekyere, K. Deterding, K. Port, J. Dietz, C. Berkowski, C. Sarrazin, M. P. Manns, M. Cornberg*, and H. Wedemeyer*. 2019. Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses. J Hepatol 71: 889–899. PMID: 31295532 *contributed equally
Rinker, F., C. L. Zimmer, C. Höner zu Siederdissen, M. P. Manns, A. R. M. Kraft, H. Wedemeyer, N. K. Björkström*, and M. Cornberg*. 2018. Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B. J Hepatol 69: 584–593. PMID: 29758333 *contributed equally
Zhang, S., R. K. Bakshi, P. V. Suneetha, P. Fytili, D. A. Antunes, G. F. Vieira, R. Jacobs, C. S. Klade, M. P. Manns, A. R. M. Kraft, H. Wedemeyer, V. Schlaphoff*, and M. Cornberg*. 2015. Frequency, Private Specificity, and Cross-Reactivity of Preexisting Hepatitis C Virus (HCV)-Specific CD8 + T Cells in HCV-Seronegative Individuals: Implications for Vaccine Responses. J Virol 89: 8304–8317. PMID: 26041301 *contributed equally.
Owusu Sekyere, S., P. V. Suneetha, A. R. M. Kraft, S. Zhang, J. Dietz, C. Sarrazin, M. P. Manns, V. Schlaphoff*, M. Cornberg*, and H. Wedemeyer*. 2015. A heterogeneous hierarchy of co-regulatory receptors regulates exhaustion of HCV-specific CD8 T cells in patients with chronic hepatitis C. J Hepatol 62: 31–40. PMID: 25131771 *contributed equally.
Waggoner, S. N., M. Cornberg, L. K. Selin, and R. M. Welsh. 2012. Natural killer cells act as rheostats modulating antiviral T cells. Nature 481: 394–398. PMID: 22101430
Cornberg, M., A. T. Chen, L. A. Wilkinson, M. A. Brehm, S.-K. Kim, C. Calcagno, D. Ghersi, R. Puzone, F. Celada, R. M. Welsh, and L. K. Selin. 2006. Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity. J Clin Invest 116: 1443–56. PMID: 16614754